Código QR (código de barras bidimensional)

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1

Abstract Background In the PRISMS study, interferon beta-1a subcutaneously (IFN β-1a SC) reduced clinical and radiological disease burden at 2 years in patients with relapsing–remitting multiple sclerosis. The study aimed to characterize efficacy of IFN β-1a SC 44 μg and 22 μg three times weekly (ti...

Fuld beskrivelse

Na minha lista:
Principais autores: Anthony Traboulsee, David K. B. Li, Mark Cascione, Juanzhi Fang, Fernando Dangond, Aaron Miller
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2018-09-01
Serier:BMC Neurology
Fag:
Relapsing–remitting multiple sclerosis
Clinical trials
Interferon-beta subcutaneously
Disability progression
MRI
No evidence of disease activity
Online adgang:http://link.springer.com/article/10.1186/s12883-018-1145-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker